Abstract
A 41-year old male was admitted with dyspnoea in 1990. His ECG demonstrated sinus rhythm, voltage-criteria for left ventricular hypertrophy and Q waves in the lateral leads. Transthoracic echocardiography demonstrated asymmetrical septal hypertrophy (17 mm), partial systolic anterior movement of the anterior mitral valve leaflet, a dynamic sub-aortic gradient of 30 mmHg and the presence of diastolic dysfunction as demonstrated by a reversal of the E:A ratio. The diastolic dysfunction was thought to be responsible for the patient’s presenting symptoms. Hypertrophic cardiomyopathy (HCM) was diagnosed but the patient declined any medical treatment or follow-up. He presented in June 2000 with a right hemiparesis. The ECG on admission showed atrial fibrillation with a ventricular rate of 110 beats per minute (bpm). Computerized tomography of the brain did not reveal evidence of a haemorrhagic bleed and treatment was commenced with intravenous heparin and an oral anticoagulant. An echocardiogram on day 5 demonstrated no changes from his previous study. In the absence of a severe outflow tract gradient, he was commenced on verapamil 120 mg twice daily, for ventricular rate control and treatment of diastolic dysfunction. On day 18, the patient became acutely dyspnoeic. Examination revealed a heart rate of 65 bpm, blood pressure of 120/70 mmHg, a late systolic murmur loudest at the left sternal edge and crackles throughout the lung fields. A chest radiograph confirmed pulmonary oedema and treatment with intravenous diuretics and oxygen therapy was immediately initiated. The patient was unresponsive to therapy and so an emergency echocardiogram was performed. This revealed normal systolic function of the left ventricle, a maximum dynamic gradient of 150 mmHg in the left ventricular outflow tract and mild mitral regurgitation (Fig. 1). An intravenous bolus of esmolol was administered and within 10 min there was rapid improvement in the patient’s symptoms. Real-time echocardiography demonstrated a dramatic reduction in the outflow tract gradient to 16 mmHg (Fig. 2). An esmolol infusion was continued for a further 8 h and then replaced with oral beta-blocker therapy. The remainder of the patient’s stay was uneventful and he was discharged on oral
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.